MedTrace Logo

Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171

NCT00898144 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2010-11-08

No results posted yet for this study

Summary

RATIONALE: Studying Pap smears in the laboratory from women with atypical glandular cells of unspecified significance may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at Pap smears from women enrolled on clinical trial GOG-171.

Conditions

Interventions

OTHER

Papanicolaou test

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • Tsunehisa Kaku, MD · Kyushu University Hospital

  • Keiichi Fujiwara, MD, PhD · Saitama Medical University International Medical Center

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898144 on ClinicalTrials.gov